Institutional investors purchased a net $10.8 million shares of ADMA during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 64.68% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ASSENAGON ASSET MANAGEMENT SA (G... Bought 1.3 Million shares of ADMA Biologics Inc
KLP KAPITALFORVALTNING AS Bought 31.2 Thousand shares of ADMA Biologics Inc